Austedo 9 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FWCDU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,332
Award facts
- Contract value 100% obligated
- $12,332.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,332.20 to AmerisourceBergen Drug Corp for the supply of Austedo 9 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated substantial capability in federal medical procurement through its competitive contract awards with the DLA Medical Supply Chain. The company's federal contract portfolio encompasses diverse therapeutic domains including specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices. As a prime contractor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, AmerisourceBergen is well-positioned within the DLA's evolving Pharmaceutical Prime Vendor Global Program Generation V initiative, which is planned to make multiple regional awards among multiple contractors to ensure comprehensive pharmaceutical support to the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB25FWCDU?
SPE2DB25FWCDU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FWCDU worth?
The government has obligated $12,332 on SPE2DB25FWCDU.
Is contract SPE2DB25FWCDU an order under another contract?
Yes. SPE2DB25FWCDU is a delivery order under SPE2DB25D3022, an indefinite delivery contract.
Was contract SPE2DB25FWCDU competed?
The extent of competition for SPE2DB25FWCDU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award